Streetbeat News

Partnerships

SVFD

Save Foods, Inc. (NASDAQ:SVFD), an Agri-Food Tech company, has commenced commercial activities in Brazil through an exclusive local distributor, following compliance with local regulations. This move capitalizes on Brazil's significant growth in fruit exports, which saw a 6% increase in 2023, reaching 1.06 million tons. Save Foods' eco crop protection solution aims to support Brazilian packers in meeting EU market standards, particularly the EU's residue limits. The partnership with the distributor is expected to enhance the post-harvest treatment of fresh produce, starting with limes and mangos, benefiting farmers, distributors, and consumers.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 1:01 pm

GE

GE Healthcare has partnered with Biofourmis to distribute virtual care-at-home solutions in the U.S., starting Q1 2024. This collaboration aims to extend patient monitoring outside the hospital, leveraging Biofourmis' technology.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:36 pm

ASTI

Ascent Solar Technologies announced that its solar module products have been selected to fly on NASA's LISA-T mission, which is scheduled for launch this summer. This marks a significant milestone for the company, showcasing the reliability and efficiency of its solar technology in space applications.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:32 pm

ALVO

TEVA

The FDA approved Simlandi, an interchangeable biosimilar to AbbVie's Humira, developed by Alvotech and marketed by Teva Pharmaceutical Industries. This approval could impact the arthritis drug market, particularly affecting AbbVie's dominance.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:23 pm

DTEGY

SFBQF

SKM

SK Telecom, Deutsche Telekom, e& Group, Singtel, and SoftBank plan to create a Joint Venture to develop Large Language Models (LLMs) for telcos, aiming to enhance customer interactions through digital assistants and chatbots. The venture is set to be established within this year.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:23 pm

NBIX

VYGR

Voyager Therapeutics and Neurocrine Biosciences have selected a development candidate for Friedreich's Ataxia, triggering a $5M milestone payment to Voyager. Voyager is set to receive this payment in Q1 2024 and is eligible for future payments based on program advancement.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:15 pm

NBIX

VYGR

Voyager Therapeutics and Neurocrine Biosciences have selected a lead development candidate for Friedreich's Ataxia, planning to advance into human trials in 2025. The candidate utilizes a frataxin gene replacement payload and a novel capsid from Voyager's TRACER platform.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:13 pm

NTR

Cibus has entered into a development agreement with Loveland Products, a subsidiary of Nutrien (NTR), to integrate traits into Loveland's elite rice seed genetics. The collaboration aims to commercialize herbicide tolerance in rice, focusing on the southern US market's demand for innovative weed control solutions. No financial terms of the agreement were disclosed.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:12 pm

TEVA

Teva Pharmaceutical Investments Singapore, a subsidiary of Teva Pharmaceutical Industries, has partnered with Jiangsu Nhwa Pharmaceutical to market and distribute Austedo (Deutetrabenazine), a treatment for neurodegenerative and movement disorders.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:08 pm

TRNR

Interactive Strength Inc. (TRNR) has signed an exclusive worldwide distribution agreement with WOODWAY USA Inc. for the sale and distribution of its CLMBR product. The deal includes an initial order of 2,150 units from WOODWAY, expected to generate over $7 million in net revenue for TRNR. This agreement supports TRNR's revenue guidance of $15 million to $20 million for 2024.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 12:06 pm